51167-400 : Kalydeco 75 mg Oral Granule
| NDC: | 51167-400 |
| Labeler: | Vertex Pharmaceuticals Incorporated |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Kalydeco |
| Dosage Form: | Oral Granule |
| Application #: | NDA207925 |
| Rev. Date: |
NDC Package Codes:
- 51167-400-01: 56 GRANULE IN 1 CARTON (51167‑400‑01)
Active Ingredients:
- Ivacaftor
Dosage Strength:
- 75 mg
Pharmaceutical Classes:
- Chloride Channel Activation Potentiators [MoA]
- Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
- Cytochrome P450 2C9 Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 51167-200 Kalydeco 150 mg Oral Tablet by Vertex Pharmaceuticals Incorporated
- 51167-300 Kalydeco 50 mg Oral Granule by Vertex Pharmaceuticals Incorporated
- 51167-600 Kalydeco 25 mg Oral Granule by Vertex Pharmaceuticals Incorporated
- 51167-770 Kalydeco 13.4 mg Oral Granule by Vertex Pharmaceuticals Incorporated
- 51167-785 Kalydeco 5.8 mg Oral Granule by Vertex Pharmaceuticals Incorporated
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 51167-331Next: 51167-445 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.